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1. Introduction 
Nutraceutical is a term combining the words nutrition and pharmaceutical. It is a food or 
food product that provides health and medical benefits, including the prevention and 
treatment of disease. A nutraceutical has beneficial effects because it possesses many 
compounds with antioxidant and intracellular signalling-pathway modulator effects. In 
recent years, it has been demonstrated that microalgae of the Chlorophyceae class could be 
excellent nutraceuticals because they contain polyphenols, chlorophyll, -carotene, ascorbic 
acid, lycopene, -tocopherol, xanthophylls, and PUFAs. For this reason, some research 
groups, including ours, have studied the nutraceutical properties of the genera Dunalliela, 
Haematococcus, and Chlorella. However, our research group has put special emphasis on the 
genera Chlorella and Chlamydomonas. For these genera, we present new results that reveal 
antioxidant effects in different models of oxidative stress and cell damage 
2. Nutraceuticals 
For a long time, natural products obtained from plants have been used as prominent sources 
of prophylactic agents for the prevention and treatment of disease in humans, animals, and 
in plants. Hippocrates (460-370 BC) started “let food be your medicine and medicine be your 
food”. Now, the relationship between food and drugs is getting closer. 
As we enter the third millennium, with increased life expectancy and greater media 
coverage of the health care issue, consumers are understandably more interested in the 
potential benefits of nutritional support for disease control or prevention. A recent survey in 
Europe concluded that diet is rated more highly by consumers than exercise or the 
hereditary factor for achieving good health (Hardy, 2000). For that reason, many 
entrepreneurs seek to introduce different products into the health and nutritional market. 
Marketing strategies have exploited the words "functional food" and "nutraceuticals" in their 
advertisements. Nutraceuticals and functional foods are the fastest growing segment of 
today´s food industry, although nutraceuticals should be treated as pharmaceutical 
www.intechopen.com
 
Oxidative Stress and Diseases 
 
582 
products as we will detail. Nutraceuticals and functional foods are a market estimated at 
between $6 billion US and $60 billion US and it is growing at 5% per annum. Unfortunately, 
entrepreneurs in an effort to make money attract, as irresponsible market entrants, products 
that do not comply with biosafety tests. This is because there are few laws that regulate the 
production and sale of such products. Because the products are not submitted for 
standardized toxicology testing, sometimes they may be toxic for human consumption. 
There are no specific regulation in any country to control nutraceuticals, and they need to be 
established and should be considered under the same laws that regulate pharmaceuticals 
and food (Bernal et al., 2011). For our purposes, we will first define “nutraceuticals” and 
“functional foods” and how the microalgae could be excellent nutraceuticals. 
The term nutraceutical was first mentioned in 1989 to describe the union between nutrition 
and pharmaceuticals, both key contributors to human wellness. Stephen DeFelice MD is the 
founder and chairman of the Foundation for Innovation in Medicine (FIM) and he defined a 
nutraceutical as a food (or part of the food) that provides medicinal health benefits, 
including the prevention or treatment of a disease. It was proposed that a nutraceutical is 
not a drug, which is a pharmacologically active substance that potentiates, antagonizes, or 
otherwise modifies any physiological function. A nutraceutical may be a single natural 
nutrient in powder, tablet, capsule, or liquid form. It is not necessarily a complete food but 
equally not a drug (Hardy, 2000). Also, it was proposed that a nutraceutical is a product that 
delivers a concentrated form of a presumed bioactive agent from a food, presented in a 
nonfood matrix, and it is used with the purpose of enhancing health in a dosage that 
exceeds those that could be obtained from normal food (Zeisel, 1999).  
Functional food and nutraceutical are terms used incorrectly and indiscriminately for 
nutrients or nutrient-enriched food that can prevent or treat disease. Functional food is a 
product that resembles traditional food but it possesses demonstrated physiological benefits 
(Shahidi, 2009). For example a functional food could be a lutein-rich food as chicken, 
spinach, tomatoes, or oranges, or the omega-3 fatty acids found in fish oil. All functional 
foods are processed and consumed as food. A nutraceutical is not a nutritional supplement 
because the latter are nutrients that are added to the diet to correct or prevent deficiencies of 
vitamins, minerals, and proteins, and often used in the recovery of a patient suffering an 
illness or has undergone surgery, and also taken to improve overall health (Mandel et al., 
2005). The beneficial effects of nutraceuticals and functional foods have been attributed to 
their components, such as polyphenols, polyunsatured fatty acids (PUFAs), terpenes, 
chlorophyll, and accessory pigments of the photosynthetic apparatus in cyanobacteria such 
as Spirullina. In general these compounds are antioxidants that reduce intensity of oxidative 
stress or modulate intracellular communication 
3. Nutraceutical effects of polyphenols, particularly flavonoids 
The polyphenols are compounds characterized by a benzene ring bearing one or more 
hydroxyl groups attached to the ring. They are ubiquitous in the plants, vegetables, fruit, 
vines, tea, coffee and microalgae. The polyphenols in food originate from one of the main 
classes of secondary metabolites in plants. They are involved in the growth and 
reproduction and are produced as a response to defend injured plants against pathogens, 
and to participate in the defense mechanism against ultraviolet radiation (Biesalski, 2007). 
Polyphenols have different nutraceutical properties, such as an antioxidant, 
antiinflammatory (Biesalski, 2007), anticancer (Oz & Ebersole, 2010), antibacterial (Du et al., 
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2011), antiatherogenic, and antiangiogenic (Rimbach et al., 2009). There are now 
polyphenols with therapeutic properties for which the mechanism of action at the molecular 
level has been discovered and they are used in clinical trials, e.g. flavonoids.  
Flavonoids comprise the most common group of polyphenols and provide much of the 
flavor and color to fruit and vegetables. More than 6000 different flavonoids have been 
described and it is estimated that humans consume about 1 g/day. 
The structure of flavonoids is C6-C3-C6 and they consist of two aromatic rings linked 
through three carbons usually forming an oxygenated heterocycle nucleus, named the 
flavan nucleus, and shown in figure 1. In general, the flavonoids are classified into six 
groups (Grassi et al., 2009). 
1. Flavones: These kinds of flavonoids are used by angiosperms to color their flowers. 
Natural flavones include apigenin (4',5,7-trihydroxyflavone), (3',4',5,7-
tetrahydroxyflavone), (4',5,6,7,8-pentamethoxyflavone), chrysin (5,7-dihydroxyflavone), 
baicalein (5,6,7-trihydroxyflavone), scutellarein (5,6,7,4'-tetrahydroxyflavone), wogonin 
(5,7-Dihydroxy-8-methoxyflavone). There are synthetic flavones such as diosmin and 
flavoxate. 
2. Flavonols: These compounds are used by organisms to protect them from UV radiation. 
Their diversity stems from the different positions of the hydroxyl groups on the 
benzene rings (show figure 1). There are flavonols as kaempferol (3,4',5,7-tetrahydroxy-
2-phenylchromen-4-one), quercetin (3,3',4',5,7-pentahydroxy-2-phenylchromen-4-one), 
myricetin (3,3',4',5',5,7-hexahydroxy-2-phenylchromen-4-one), galangin (3,5,7-
trihydroxy-2-phenylchromen-4-one), and morin (2-(2,4-dihydroxyphenyl)-3,5,7-
trihydroxychromen-4-one). Flavanones: These flavonoids are the direct precursors of 
the vast majority of flavonoids. Some examples of flavanones are: naringenin (4',5,7-
trihydroxyflavanone) and butin (7,3',4'-trihydroxyflavanone).  
3. Catechin or flavanols: These flavonoids have two chiral centers on the molecule on 
carbons 2 and 3, yielding four diastereoisomers. Two of the isomers are in the trans 
configuration and are called catechins and the other two are in the cis configuration and 
are called epicatechins. These flavonoids are present in food as a complexs or 
oligomerics and polymerics as procyanidins or proantocyanidins. The catechins are 
found in different fruits, i.e. apples, apricots, blackberries, and grapes. Catechins are 
also in red wine, but black tea and cocoa are the richest sources. The flavanols in  
finished food products depend on the cultivar type, geographical origin, agriculture 
practice, postharvesting handling, and food processing (Scalbert et al., 2005). 
4. Antocyanidins: Antocyanidins are a large group of natural colorants. The color of most 
fruits, flowers, and berries are made from a combination of anthocyanins and 
anthocyanidins. Anthocyanins always contain a carbohydrate molecule, whereas 
anthocyanidins do not. Examples of antocyanidins are cyanidin (3,3',4',5,7-
pentahydroxyflavylium chloride), pelargonidin (3,5,7-trihydroxy-2-(4-hydroxyphenyl) 
benzopyrylium chloride), and malvidin (3,5,7,4'-tetrahydroxy-3',5'-dimethoxyflavylium) 
5. Isoflavones: This group is a class of organic compounds that sometimes act as 
phytoestrogens in mammals and are called antioxidants because of their ability to trap a 
singlet oxygen. Genistein (4',5,7-trihydroxyisoflavone) and daidzein (4',7-
dihydroxyisoflavone) are two examples of isoflavones. 
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Some authors have proposed that aurones are another flavonoid group, however we 
consider that aurones are derived from chalcones (Fowler & Koffas, 2009). 
The flavonoid synthesis is shown in figure 1. It begins when a cell transforms phenylananine 
or tyrosine into phenylpropanoic acid or cinnamic acid by phenylalanine-tyrosine ammonia 
lyase (PAL; EC 4.3.1.25/TAL; EC 4.3.1.25). Then cytochrome-P450 cinnamate 4-hydroxylase 
(C4H; EC 1.14.13.11) adds a 4´-hydroxyl group to form p-coumaric acid. The CoA esters are 
subsequently synthetized from cinnamic acid, caffeic acid, or p-coumaric acid by 4-
coumaryl:CoA ligase (4CL; EC 6.2.1.12). The type III polyketide chalcone synthase (CHS; EC 
2.3.1.74) catalyzes the sequential condensation of three malonyl-CoA moieties with one 
CoA-ester molecule to form chalcones. The flavanones are formed when chalcones are 
isomerized into (2S)-flavanones by chalcone isomerase (CHI; EC 5.5.1.6). Many enzymes can 
modify the flavanones. For example the flavanones could be reduced to form isoflavones by 
isoflavone synthase (IFS; EC 1.14.13.86). After that, isoflavones are modified by different 
enzymatic systems to produce hydroxylation, reduction, alkylation, oxidation, and 
glucosylation alone or in combination in the three-ring phenylpropanoid core. Enzymes 
such as O-methyltransferse (IOMT, EC 2.1.1.150), isoflavone 2´-reductase (I2´R; EC 1.3.1.45), 
andisoflavone reductase (IFR; EC 1.3.1.45) can yield over 8000 different chemical structures 
from isoflavone (Winkel-Shirley, 2001; Fowler & Koffas, 2009). Another branch of the 
biosynthetic pathway of flavonoids is the flavones that are synthesized from flavanones 
through the action of the flavone synthase type I and II (FSI; EC 1.14.11.22). Flavonones are 
hydroxylated and then with flavonol synthase (FLS; EC 1.14.11.23) form flavonols. These 
compounds are the precursors of anthocyanins. 
The beneficial effects can be divided into 
1. Antioxidants: Flavonoids suppress the formation of reactive oxygen species (ROS) 
either by inhibiting enzymes or chelating trace elements involved in free radical 
production. Thus flavonoids help maintain an ROS steady state in the case of physical 
and chemical injury of the cell (Corradini et al., 2011). Not all flavonoids are ROS 
scavengers because some flavonoids, as nucleophiles, trap electrons from the ROS and 
become a free radical themselves, which then propagate a chain reaction causing a 
deleterious effect in the cell (Grassi et al., 2009).   
2.  Modulators of intracellular communication: The flavonoids and their metabolites act 
in the phosphoinositide 3-kinase (PI3K), Akt-protein kinase B (Akt-PKB), tyrosine 
kinase, and protein kinase C (PKC) signalling cascade. The inhibition or activation of 
these cascades modifies cellular function by altering the phosphorylation state of target 
molecules that modulate the expression of genes. This can explain the anticancer and 
neuroprotector flavonoid activities (Williams et al., 2004).  
3. Enzyme activity modulator: Flavonoids offer cardiovascular protection because of their 
indirect inhibition of the angiotensin-converting enzyme (ACE; EC 3.4.15.1) (Actis-
Goretta et al., 2006). Other enzymes inhibited by flavonoids are aromatase (EC 1.14.14.1) 
andamylase (EC 3.2.2.1) (Hargrove et al., 2011). The inhibition of enzymes that have 
a Fe-S cluster has been demonstrated (Mena et al., 2011). 
In general, flavonoids are molecules responsible of some of the beneficial effect of 
nutraceuticals and functional foods. The different effects of flavonoids are described in 
table 1.  
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Fig. 1. Scheme of the major branch pathways of flavonoid biosynthesis, starting with general 
phenylpropanoid metabolism and leading to the nine major subgroups; chalcones, aurones, 
isoflavonoids, flavones, flavonols, flavandiols, anthocyanins, condensed tannins, and 
phlobaphene pigments  
www.intechopen.com
 
Oxidative Stress and Diseases 
 
586 
Flavonoid Nutraceutic application Reference 
Flavanones 
LDL oxidation (atherosclerosis) 
Cyclooxygenase inhibitory ability 
(cancer) 
Malaria  chemotherapy (malaria) 
Inflammation response trigger (reduce 
inflammation) 
Antiangiogenic effect 
Reduce lung metastases 
Hepatoprotective action 
Antibacterial action 
Genoprotective action 
Inhibitors of NOS and COX in microglia 
Promote apoptosis in C6 glioma cells 
(Miranda et al., 2000) 
(Kinghorn et al., 2004) 
(Kumar et al., 2003) 
(Kontogiorgis et al., 2008) 
(Mojzis et al., 2008) 
(Qin et al., 2011) 
(Prabu et al., 2011) 
(Celiz et al., 2011) 
(Orsolic et al., 2011) 
(Chao et al., 2010) 
(Sabarinathan et al., 2010) 
Flavones 
GLUT inhibitors (diabetes) 
Cyclooxygenase inhibitory ability 
(cancer) 
Antitumoral activity 
Pancreatic cholesterol esterase inhibitor 
Reduce neurodegeneration 
Produce apoptosis in melanoma cells 
Colitis treatment 
Antiinflammatory effect 
(Kwon et al., 2007) 
(Kinghorn et al., 2004) 
(Balk, 2011; Polier et al., 
2011) 
(Peng et al., 2011) 
(Gasiorowski et al., 2011) 
(Mohan et al., 2011) 
(Ganjare et al., 2011) 
(Funakoshi-Tago et al., 2011) 
Flavonols 
GLUT inhibitors (diabetes) 
Pancreatic lipase inhibitors (diabetes) 
Inhibitors of cell cycle control kinases 
(cancer) 
Regulate lipid profile in diabetic rats 
Regulate serum glucose 
Reduce apoptosis in cell culture 
Hepatoprotective action 
Promote new bone formation 
Anti-inflammatory effect 
Reduce neuronal damage 
 
(Kwon et al., 2007; Park & 
Levine, 2000) 
(Nakai et al., 2005) 
(Hsu & Yen, 2006) 
(Liu et al., 2012) 
(Fontana Pereira et al., 2011) 
(Jang et al., 2011) 
(Singab et al., 2010) 
(Yang et al., 2010) 
(Mahat et al., 2010) 
(Lagoa et al., 2009) 
(Hirose et al., 2009) 
Isoflavonoids 
Alpha-glucosidase inhibitor (diabetes) 
GLUT inhibitor (diabetes) 
Improves cholesterol regulation 
(diabetes) 
Inhibitor of tyrosine kinase and 
antiinflammatory effect in kidney 
Induce apoptosis in leukemia 
Neuroprotective action 
Antiinflammatory action 
 
(Kim et al., 2000) 
(Kwon et al., 2007; Song et 
al., 2002) 
(Lee, 2006) 
(Elmarakby et al., 2011) 
(Li et al., 2011a) 
(Xi et al., 2011) 
(Neelakandan et al., 2011) 
Anthocyanins Pancreatic lipase and glucosidase (Kim et al., 2000) 
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Flavonoid Nutraceutic application Reference 
inhibitor (diabetes) 
Regulate adipocyte function (Obesity) 
Improves glucose and lipid metabolism 
(diabetes) 
Modulate blood hormone levels 
(multiple sclerosis) 
Suppress body fat accumulation(obesity) 
Reduce neuropathic hyperalgesia  in 
diabetic rats 
Antioxidant effect 
Neuroprotective action 
produce cytotoxicity in colon cancer cells 
(Tsuda, 2008) 
(Wolfram et al., 2006) 
(Sternberg et al., 2008) 
(Tokimitsu, 2004) 
(Mirshekar et al., 2010) 
(Wang et al., 2010) 
(Roghani et al., 2010) 
(Cvorovic et al., 2010) 
Table 1. Nutraceutical applications of flavonoids. 
The mechanism of bioavailability and metabolism of particular flavonoids has been 
demonstrated in mammals. In general it has been shown that flavonoid absorption and 
metabolism occurs in a common pathway and it begins in the stomach and intestinal tract. 
In the small intestine flavonoids pass into the bloodstream in the form of glycosides, though 
esters or polymers cannot be absorbed. Some intestine cell enzymes or microorganisms of 
microflora hydrolyze them to be absorbed. In the bloodstream there are different 
thermodynamic pathways. They could interact with cells to modify intracellular 
communication. The polyphenols can be conjugated in the intestine or liver to form 
methylated, glucuronidated, or sulphated metabolites that reach the body via urinary and 
biliary excretion. The microflora also metabolizes some metabolized flavonoids that are 
secreted in the bile into the small intestine. Thus, there is a recycling of polyphenols that 
allow them more time in the plasma (Erdman et al., 2007; Manach et al., 2004). In general, 
the microalgae produce low quantities of polyphenols. For this reason, in the following 
parts of this chapter we give special attention to pigments and PUFAs.  
4. Nutraceutical effects of terpenes 
The terpenes are other secondary metabolites that have nutraceutical properties. The 
terpenes are not only the largest group of plant natural products, comprising at least 30,000 
compounds, but also contain the widest assortment of structural types. Hundreds of 
different monoterpene (C10), sesquiterpene (C15), diterpene (C20), and triterpene (C30) 
carbon skeletons are known. The wealth of terpene carbon skeletons can be attributed to an 
enzyme class known as the terpene synthases (EC 4.2.3.20). These catalysts convert the 
acyclic prenyl diphosphates and squalene into a multitude of cyclic and acyclic forms. The 
chief causes of terpene diversity are the large number of different terpene synthases and that 
some terpene synthases produce multiple products. An excellent review of terpene synthase 
and the diversity of products were published by Degenhard and coworkers (Degenhardt et 
al., 2009). Microalgae produce terpenes in the form of carotenoids. These compounds offer 
therapeutic effects. Carotenoids are tetraterpenoid organic pigments that are naturally 
occurring in the chloroplasts and chromoplasts of photosynthetic organisms. The use of 
carotenoids by animals is because they cannot synthetize them. Animals obtain carotenoids 
in their diets, and they may employ them in various ways in their metabolism. 
www.intechopen.com
 
Oxidative Stress and Diseases 
 
588 
There are over 600 known carotenoids and they are divided into two classes, xanthophylls 
(that contain oxygen) and carotenes (that are purely hydrocarbons and contain no oxygen). 
Carotenoids in general absorb blue light. They serve two key roles in plants and algae; they 
absorb light energy for use in photosynthesis and they protect chlorophyll from 
photodamage (Armstrong & Hearst, 1996). 
The biosynthesis of carotenes is explained in figure 2. The carotenogenesis differ somewhat 
among organisms and the current knowledge on the biosynthesis of carotenoids has been 
gained mainly from studies of bacteria and vascular plants (Armstrong & Hearst, 1996). In 
Figure 2, we proposed the model of Lohr for the carotenogenesis in Chlamydomonas. This is 
probably related to other microalgae of Chlorophyceae class (Lohr et al., 2005; Lohr, 2008). 
There are other major divisions in different organisms, such as diatoms (Bertrand, 2010) or 
plants (Cazzonelli & Pogson, 2010; Zhu et al., 2010), which references the readers can check 
to deepen their knowledge in this area. 
There has been much interest in carotenoids, especially their effect on human health, 
because they have a market value of several hundred million Euros. Their chemical 
synthesis is still a demanding challenge for chemists. The major dietary source of vitamin A 
for mammals, including humans, is derived from carotenoids. Vitamin A is an essential 
micronutrient for cell growth, embryonic development, vision, and the function of the 
immune system (Jackson et al., 2008). 
In general carotenoids exert their mechanism on health via an antioxidant pathway or by 
modulating intracellular communication. 
1. Antioxidant properties: This property of carotenoids was characterized by the ability to 
quench singlet oxygen, the inhibition of peroxide formation, and the correlation of 
antioxidant dependency with oxygen partial pressures. The ketocarotenoids, such as 
astaxanthin and canthaxanthin, were the best radical scavengers that did not contain 
conjugated terminal carbonyl functions (see figure 2). These findings suggest that the 
keto function in conjugation with the polyene backbone is able to stabilize carbon-
centered radicals more effectively than the polyene backbone alone (Jackson et al., 
2008).  
2. Modulation of intracellular communication: Carotenes modulate the intracellular 
communication because they or their metabolites interact with nuclear receptors like 
the pregnant-X-receptor (PXR) or retinoic acid receptor (RAR). For PXR it has been 
postulated that -carotene activated the PXR more than its metabolites. Following this 
pathway, the -carotene-PXR enhanced the metabolism of xenobiotics, bile acids, and 
retinoids (Ruhl, 2005). The carotenoids can be converted into two molecules of 9-cis-
retinal, which is oxidized to 9-cis-retinoic acid. The RXR binds the 9-cis-retinoic acid 
with high affinity to modulate cell functions (Heyman et al., 1992). Carotenoids like 
lycopene modulate mevalonate and Ras pathways to modify cell growth inhibition of 
cancerous cells (Palozza et al., 2010), and it changes Wnt and hedgehog proteins in 
those cells (Sarkar et al., 2010). The PI3K-Akt and MAPK pathways are stimulated in 
kidney by lycopene (Chan et al., 2009).  
In table 2, are some nutraceuticals of the most used carotenoids. 
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Fig. 2. Putative pathways of carotenoid biosynthesis in Chlamydomonas. Hypothetical 
zygospore-specific pathways are indicated by dotted arrows. For the enzymes of the 
pathways only abbreviations are given. DXS (1-deoxy-D-xylulose-5-phosphate synthetase, 
EC 2.2.1.7). DXR ( 1-deoxy-D-xylulose-5-phosphate reductoisomerase, EC 1.1.1.267). CMS (4-
diphosphocytidil-2-C-methyl-D-erythriol synthase, EC 2.7.7.60). CMK (4-diphosphocytidil-
2-C-methyl-D-erythriol kinase, EC 2.7.1.14.8). MCS (2-C-methyl-D-erythritol-2,4-
cyclophosphate synthase, EC 4.6.1.12). HDS (4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase, EC 1.17.7.1). IDS (isopentenyl dimethylallyl diphosphate synthase, EC 1.17.1.2.3). 
IDI (isopentenyl-diphosphate delta-isomerase, EC 5.3.3.2). GGPPS (geranylgeranyl-
diphosphate synthase, EC 2.5.1.81). PSY (phytoene synthase, EC 2.5.1.32). PDS (phytoene 
desaturase, EC 1.3.5.5). Z-ISO (-Carotene isomerase); ZDS (-carotene desaturase, EC 
1.3.5.6). CRTISO (carotenoid isomerase, EC 5.2.1.13). LCYB (lycopene--cyclase). LCYE 
(lycopene--cyclase), CHYB (carotene--hydroxylase, EC 1.14.13.-). CYP97A5 (carotene--
hydroxylase, EC 1.14.13.129). CYP97C3 (carotene--hydroxylase, EC 1.14.99.45). ZEP 
(zeaxanthin epoxidase, EC 1.14.13.90). VDE (violaxanthin epoxidase, EC 1.10.99.3). NSY 
(neoxanthin synthase, EC 5.3.99.9). LSY (loroxanthin synthase), and BKT (carotene--
ketolase).  
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Carotenoid Nutracetical effect Reference 
 Antimutagenic effect (Polivkova et al., 2010) 
Neuroprotective action (Sandhir et al., 2010) 
Nephroprotective action (Sahin et al., 2010) 
Prevent preclampsia (Banerjee et al., 2009) 
Reduce risk of hip fracture (Sahni et al., 2009) 
Antioxidant effect (Erdman et al., 2009) 
Reduce eosinophil influx in asthma (Wood et al., 2008) 
Cardioprotective effect against doxorubicin– 
caused damage 
(Anjos Ferreira et al., 
2007) 
Reduce inflammatory cytokines expression in 
pancreatitis 
(Kim, 2011a; Kim, 2011b) 
Inhibit the growth and progression of colon 
cancer 
(Tang et al., 2011) 
Enhanced antioxidant enzymes and 
immunity function in gastric cancer 
(Luo & Wu, 2011) 
Inhibit NFB–modulated IL-8 expression in 
macrophages–cigarette activated 
(Simone et al., 2011) 
Reduced oxidative stress in allergic rhinitis (Li et al., 2011b) 
Attenuated endothelial dysfunction in 
diabetes 
(Zhu et al., 2011) 
Reduce cognitive decline in Parkinson’s 
disease  
(Kaur et al., 2011) 
Reduces LDC cholesterol and systolic blood 
pressure 
(Ried & Fakler, 2011) 
 Reduces endothelial dysfunction in diabetic 
rats 
(Zhao et al., 2011)z 
Produces anxiolytic–like effects in mice (Nishioka et al., 2011) 
Reduces oxidative stress and mitochondrial 
dysfunction  in brain due MPTP/MPTP+ 
(Lee et al., 2011) 
Reduce IL-6 microglia production (Kim et al., 2010) 
Reduce blood pressure in hypertensive rats (Monroy-Ruiz et al., 2011) 
Neuroprotective action against focal ischemia (Lu et al., 2010) 
Attenuate thrombosis (Khan et al., 2010) 
Reduce retinal injury in elevated intraocular 
pressure 
(Cort et al., 2010) 
Reduce UVA – induced skins photoaging (Suganuma et al., 2010) 
Hepatoprotective action (Curek et al., 2010) 
Table 2. Nutraceutical application of lycopene and astaxanthin. 
Carotenoids are lipid soluble and in general they follow the same absorption pathway as 
lipids, however other mechanisms of absorption have been proposed. To learn more, read 
the review of Kotake-Nara and Nagao (Kotake-Nara & Nagao, 2011). Once in the 
bloodstream, carotenes are fundamentally ligated to low density lipoprotein (LDL) whereas 
the xanthophylls are more evenly distributed between high density lipoproteins (HDL) and 
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low density lipoproteins (LDL). Nonpolar carotenoids (lycopene, ǂ-carotene, ǃ-carotene) are 
located in the hydrophobic core and the polar (xanthophylls) would be, at least in part, on 
the surface of lipoproteins (Furr & Clark, 1997). For the microalgae, carotenoids are 
synthesized in high concentrations under several different environmental conditions, and 
humans exploited these as nutraceuticals in food.  
5. Nutraceutical effects of chlorophylls, PUFA and other vitamins 
There are other components in microalgae that could modulate redox environment to 
prevent oxidative stress and can affect intracellular communication. These components are 
chlorophyll, PUFAs, and vitamins such as vitamin A, B, C, and E. 
Microalgae, like all chloroplast-containing photosynthetic eukaryotes, synthesize 
chlorophyll pigments. In Chlorophyceae chorophylls a and b are the most predominant. The 
chlorophylls have a porphyrin ring structure similar to heme, but with a central nonreactive 
magnesium ion instead of iron. To review chlorophyll biosynthesis in microalgae, read the 
chapter of Beale (Beale, 2008). The information about the biological activities of chlorophyll 
as nutraceuticals is scarce. They do have antipoliferative (Wu et al., 2010) and antioxidant 
(Serpeloni et al., 2011) activities. The chlorophyllin-cooper complex, a water-soluble 
commercial version of chlorophyll, possesses antimutagenic (Chernomorsky et al., 1997) and 
anticancer activities (Chernomorsky et al., 1997). The other components of microalgae; 
PUFAs, and vitamins A, B, C, and E, could be a nutraceutical because there is much 
evidence of how they modulate intracellular signals and act as antioxidants. 
6. Chlorella genus as nutraceutic 
Chlorella species are encountered in all water habitats having cosmopolitan occurrences. The 
species of this genus have a simple form, a unicellular green alga belonging to the 
Chlorophyceae family. The Chlorella sp. is morphologically classified into four types; a) 
spherical cells (ratio of the two axes equals one), b) ellipsoidal cells (ratio of the longest axis 
to the shorter axis 1.45 to 1.60), spherical or ellipsoidal cells, and globular to subspherical 
cells. Their reproduction is asexual. Each mature cell divides usually producing four or eight 
(and more rarely 16) autospores, which are freed by rupture or dissolution of the parental 
walls.  
Our research group has used Chlorella vulgaris as nutraceutical, particularly against 
mercury-caused oxidative stress and renal damage. For that we used male mice that were 
assigned into six groups; 1) a control group that received 100 mM phosphate buffer (PB) ig 
and 0.9% saline ip, 2) PB + HgCl2 5 mg/kg ip, 3) PB + 1000 mg/kg Chlorella vulgaris ig, and 
three groups receiving HgCl2 + 250, 500, or 1000 mg/kg Chlorella vulgaris ig. The 
administration of the microalgae or PB was made 30 min before saline or HgCl2 for 5 days. 
Our results demonstrated that HgCl2 caused oxidative stress and cellular damage, whereas 
Chlorella vulgaris administration prevents oxidative stress (figure 3) and cellular damage 
(figure 4) in the kidney (Blas-Valdivia et al., 2011). We proposed that Chlorella vulgaris’s 
carotenes play an important role in preventing HgCl2-caused lipid peroxidation. Carotenes 
have a wide pharmacological spectrum of effects. The inhibition of lipid peroxidation may 
www.intechopen.com
 
Oxidative Stress and Diseases 
 
592 
be caused by the free radical scavenging property of these compounds (Miranda et al., 2001). 
Carotenes can scavenge singlet oxygen and they terminate peroxides by their redox 
potential because of the hydroxyl group in its structure. Thus, the ROS-steady state is 
maintained in the kidney damage lower than in animals with mercury intoxication. The 
biochemical behavior of this microalgae against mercury-caused oxidative stress is similar to 
the purified component of cyanobacteria such as Pseudoanabaena tenuis (Cano-Europa et al., 
2010) or Spirulina maxima (Sharma et al., 2007). 
. 
Fig. 3. Quantification of relative kidney weight (A) and the score of kidney damage (B) of 
mice treated with HgCl2 and Chlorella vulgaris. In A each bar represents the mean ± S.E.M. In 
B each box represents the median ± intercuartilic space.* P < 0.05 vs. control. Author right 
permission. Springer ©. 
 
Fig. 4. Quantification of lipid peroxidation (A) and reactive oxygen species in the kidneys of 
mice treated with HgCl2 and Chlorella vulgaris. Bar represents the mean ± S.E.M.* P < 0.05 vs. 
control. Author right permission. Springer ©. 
Here are some experiments that demonstrated the nutraceutical use of Chlorella (Table 3). 
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Study Evidences 
The administration of Chlorella sp. 
reduces  endotoxemia, intestinal 
oxidative stress and bacterial traslocation 
in experimental biliary obstruction 
(Bedirli et al., 2009) 
Chlorella administration inhibits bacterial 
culture and it avoids oxidative stress. 
Hot water extract of Chlorella vulgaris 
induced DNA damage and apoptosis 
(Yusof et al., 2010) 
The extract of Chlorella vulgaris inhibited 
DNA synthesis, causing apoptosis and it 
increases p53, caspase-3, and Bax expression 
in hepatoma cells (HEpG2) 
Attenuating effect of Chlorella 
supplementation on oxidative stress and 
NFκB. Activation in peritoneal 
macrophages and liver of C57BL/6 mice 
fed on atherogenic diet (Lee et al., 2003)  
Chlorella supplementation decreases the 
NFκB activation and superoxide anion 
production and because it increases SOD 
and catalase activity 
Chlorella accelerates dioxin excretion in 
rats  (Morita et al., 1999) 
Chlorella enhanced dioxin metabolism and 
excretion by feces 
Effect of Chlorella and its fractions on 
blood pressure, cerebral stroke lesions, 
and life-span in stroke-prone 
spontaneously hypertensive rats  
(Sansawa et al., 2006) 
A Chlorella supplemented diet decreases 
blood pressure and the incidence rate of 
cerebral stroke in SHRSP. 
Hypocholesterolemic mechanism of 
Chlorella: Chlorella and its indigestible 
fraction enhance hepatic cholesterol 7ǂ-
hydroxylase in rats  (Shibata et al., 2007) 
Chlorella powder increases the expression of 
CYP7A1, a limiting enzyme of the main 
pathway of the cholesterol catabolism, 
lowering the concentration of LDL in plasma 
Chlorella vulgaris triggers apoptosis in 
hepatocarcinogenesis-induced rats  
(Mohd Azamai et al., 2009) 
Chlorella vulgaris inhibits the anti-apoptotic 
protein Bcl-2 
Effect of Chlorella vulgaris on lipid 
metabolism in Wistar rats fed high fat 
diet  (Lee et al., 2008) 
Chlorella vulgaris decreases HDL cholesterol 
concentration by a reduction in the intestinal 
absortion 
Antioxidant effect of the marine algae 
Chlorella vulgaris against naphthalene-
induced oxidative stress in the albino rats   
(Vijayavel et al., 2007) 
Chlorella vulgaris inhibits production of free 
radicals, decreasing lipoperoxidation, and 
increasing the activity of antioxidant 
enzymes as SOD, catalase, GPX and reduced 
glutathione, preventing from the toxicity of 
naftalene 
Six-week supplementation with Chlorella 
has favorable impact on antioxidant 
status in Korean male smokers (Lee et al., 
2010) 
Chlorella supplement exhibits antioxidant 
activity decreasing ROS and increasing the 
activity of SOD and catalase 
Chlorella pyrenoidosa supplementation 
reduces the risk of anemia, proteinuria 
and edema in pregnant women (Nakano 
et al., 2010) 
Chlorella pyrenoidosa exhibits an 
antiinflammatory activity regulated by 
cytokine. It increased the production of IL-10 
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Study Evidences 
Effect of Chlorella intake on cadmium 
metabolism in rats (Shim et al., 2009) 
Chlorella inhibits cadmium absorption and it 
promotes the excretion through the feces. 
Also, it stimulates the production of 
metallothionein in the small intestine. 
Isolation of phophorylated 
polysaccharides from algae: the 
inmmunostimulatory principle of 
Chlorella pyrenoidosa (Suarez et al., 2010) 
The Chlorella polysaccharides increases the 
production of NO in macrophages 
enhancing the innate immune response, 
mediated by Toll-like receptors (TLR-4) 
Influence of Chlorella powder intake 
during swimming stress in mice 
(Mizoguchi et al., 2011)  
Chlorella vulgaris exhibits an antioxidant 
activity, reducing the lipoperoxidation, 
avoiding the DNA damage. However it does 
not show hypoglycemic activity 
Table 3. Nutraceutical evidences of Chlorella. 
7. Chlamydomonas genus as nutraceutic 
Chlamydomonas spp. are unicellular algae with cell walls and with either two or four flagella. 
The genus Chlamydomonas is of worldwide distribution and is found in a diversity of 
habitats including temperate, tropical, and polar regions. Chlamydomonas species have been 
isolated from freshwater ponds and lakes, sewage ponds, marine and brackish waters, 
snow, garden and agricultural soil, forests, deserts, peat bogs, damp walls, sap on a 
wounded elm tree, an artificial pond on a volcanic island, mattress dust in the Netherlands, 
roof tiles in India, and a Nicaraguan hog wallow. These algae belong to the family 
Chlamydomonadaceae that consists of approximately 30 genera. DNA sequence analysis 
clearly demonstrates, however, that this family is composed of multiple phylogenetic 
lineages that do not correspond to the morphologically defined genera. Although the 
identities of the species are uncertain, it is noteworthy that the traits in which they differed 
included body shape, thickness of the cell wall, presence or absence of the apical papilla, 
lateral vs. basal position of the chloroplast, chloroplast position, and shape of the eyespot, all 
of which were later used as criteria to separate species. Although cell-body shape and size 
vary among Chlamydomonas species (as defined by morphological criteria), the overall polar 
structure, with paired apical flagella and basal chloroplast surrounding one or more 
pyrenoids, is constant. Cells are usually free-swimming in liquid media but on solid 
substrata may be nonflagellated, and are often seen in gelatinous masses similar to those of 
the algae Palmella or Gloeocystis in the order Tetrasporales. This condition has been referred to 
as a palmelloid state. Some species may also form asexual resting spores, or akinetes, in 
which the original vegetative cell wall becomes much thicker, and carotenoids, starch, and 
lipids may accumulate  (Harris et al., 2008).  
Our group has studied the nutraceutical properties of Chlamydomonas gloeopara, a microalgae 
collected from a eutrophic reservoir (La Piedad Lake) in Cuautitlan Izcalli, Mexico. That 
reservoir is located at 19°39´N (latitude) and 99°14´W (longitude). Our research group has 
used Chlamydomonas gloeopara as a nutraceutical, particularly against mercury-caused 
oxidative stress and renal damage. For that we used male mice that were assigned into six 
groups; 1) a control group that received 100 mM phosphate buffer (PB) ig and 0.9% saline ip, 
2) PB + HgCl2 5 mg/kg ip, 3) PB + 1000 mg/kg Chlamydomonas gloeopara ig, and three 
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groups receiving HgCl2 + 250, 500, or 1000 mg/kg Chlamydomonas gloeopara ig. The 
administration of the microalgae or PB was made 30 min before saline or HgCl2 for 5 days. 
Our results demonstrated that Chlamydomonas gloeopara as well as Chlorella prevents renal 
damage (figure 5, panel A-F) by reducing the oxidative stress of lipid peroxidation (figure 5, 
panel G). 
 
Fig. 5. Effect on Chlamydomonas gloeopara administation on HgCl2-caused renal damage 
(panel A-F) and oxidative stress (panel G and H). Photomicrographs of renal cortex . Panel 
A shows control group. Panel B shows group treated with HgCl2. Panel C shows group 
treated with Chlamydomonas gloeopara 1000 mg/kg . Panels D, E and F show groups treated 
with Chlamydomonas gloeopara 250, 500 and 1000 mg/kg plus HgCl2. The tissue was stained 
by hematoxylin-eosin. Treatment with HgCl2 causes cell atrophy, hyperchromatic nuclei, 
and edema. Histological alterations were partially ameliorated in groups treated with 
Chlamydomonas gloeopara. Chlamydomonas gloeopara administration reduced lipid 
peroxidation (G) and reactive oxygen species (H) in the kidneys of mice treated with HgCl2 
and Chlorella vulgaris. Bar is the mean ± SE * P < 0.05 vs. control. 
8. Haematococcus genus as nutraceutic 
Haematococcus are green microalgae; single-celled aquatic organisms. It is known that 
Haematococcus is the primarily source of astaxanthin, a ketocarotenoid that is a natural 
nutritional component. In the marine environment, astaxanthin is biosynthesized in the food 
chain, within the microalgae or phytoplankton, at the primary production level. When these 
algae are exposed to harsh environmental conditions and ultraviolet light, they accumulate 
the highest level of astaxanthin and in this process, the algae become blood red. Astaxanthin 
accumulates 2% to 3% of dry weight and constitutes 85% to 88% of the total carotenoids. 
Chemically it is a ketocarotenoid (3,3´-dihydroxy-ǃ, ǃ-carotene-4,4´dione) and is the 
principal pigment of salmonoids and shrimp. Astaxanthin has a higher antioxidant activity 
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than lutein, lycopene, ǂ or ǃ-carotene, and ǂ-tocopherol. Astaxanthin has 100 times and 10 
times greater antioxidant activity than vitamin E and -carotene (Guerin, 2003). 
Morphological studies have shown that the algae have a life cycle. The, green vegetative 
cells with two flagellae grow autotrophycally in the light and heterotrophically in the dark. 
In culture, H. pluvialis has the typical characteristics of a motile stage, with biflagellate 
spherical cells. The growth in a bioreactor, with mechanical stirring, favors the occurrence of 
more or less mature aplanospores. This stage becomes dominant together with the evolution 
of growth.  The aplanospore color turns gradually red, because of the accumulation of 
carotenoids in the chloroplast, and especially outside of them in lipid globules (astaxanthin). 
The red aplanospores are known as haematocysts. This stage may appear under stress 
conditions caused by light, high temperature, increased salinity, nutritional limitation, or 
change of carbon source. During the growth stage, the cells with a diameter of 30 µm were 
spherical to ellipsoid and enclosed by a cell wall. The cells had 2 flagellae of equal length 
emerging form an anterior papilla. As they age, the cells ceased to be mobile, yet the cellular 
structure remained the same without the flagellae. Under stress conditions, the volume of 
the cells increased to a diameter of > 40 µm and the cell wall became resistant. The 
maturation of the cyst cells was accompanied by enhanced carotenoid biosynthesis and a 
gradual change in cell color to red. When the cystic cells were transferred to optimal growth 
conditions, daughter cells were released from the cystic cells, and then vegetative cells 
regenerated from daughter cells (Cysewski & Todd Lorenz, 2004). 
Haematococcus has the potential as a nutraceutical because there is various evidence of this. 
In table 4, we show some articles that employed Haematococcus or its astaxanthin. 
 
Study Evidences 
Haematococcus astaxanthin: applications 
for human health and nutrition (Guerin, 
2003) 
This is a review about the uses of astaxantin 
from Haematococcus in health 
Optimization of microwave-assisted 
extraction of astaxanthin from 
Haematococcus pluvialis by response 
surface methodology and antioxidant 
activities of the extracts (Zhao et al., 2009) 
The extracts have a high antioxidant 
capacity, inhibit peroxidation of linoleic acid, 
and neutralize free radicals 
 
Cardioprotection and myocardial salvage 
by a disodium disuccinate astaxanthin 
derivative (Cardax™) (Gross & 
Lockwood, 2004) 
The astaxanthin is an antioxidant, 
antiinflammatory, and cardioprotective. 
reducer of levels of nitric oxide, tumor 
necrosis factor alpha, and prostaglandin E2 
Ulcer preventive and antioxidative 
properties of astaxanthin from 
Haematococcus pluvialis (Kamath et al., 
2008) 
The astaxanthin exerts its gastroprotection of 
gastric ulceration by activation of 
antioxidant enzyme such as catalase, 
superoxide dismutase, and glutathione 
peroxidase. It inhibits the activity pump Na-
K ATPase 
Safety assessment of astaxanthin-rich 
microalgae biomass: acute and 
subchronic toxicity studies in 
The administration of astaxanthin has no 
adverse effects 
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Study Evidences 
rats(Stewart et al., 2008)  
Astaxanthin, a carotenoid with potential 
in human health and nutrition (Hussein 
et al., 2006). 
The antihypertensive and neuroprotective 
potentials of the compound 
Protective effects of Haematococcus 
astaxanthin on oxidative stress in healthy 
smokers (Kim et al., 2011). 
The results suggest that ASX 
supplementation might prevent oxidative 
damage in smokers by suppressing lipid 
peroxidation and stimulating the activity of 
the antioxidant system in smokers 
Astaxanthin-rich extract from the green 
alga Haematococcus pluvialis lowers 
plasma lipid concentrations and enhances 
antioxidant defense in apolipoprotein E 
knockout mice (Yang et al., 2011) 
It results suggest that supplementation of 
astaxanthin-rich Haematococcus extract 
improves cholesterol and lipid metabolism 
as well as antioxidant defense mechanisms, 
all of which could help mitigate the 
progression of atherosclerosis. 
Table 4. Nutraceutical evidences of Haematococcus. 
9. Dunaliella genus as nutreutic 
Dunaliella salina is a unicelular green alga belonging to the Chlorophyceae family. Dunaliella 
cells are ovoid, spherical, pyriform, fusiform, or ellipsoid with sizes varying from 5 to 25 µm 
in length and from 3 to 13 µm in width. The cells also contain a single chloroplast, which 
mostly has a central pyrenoid surrounded by starch granules. Dunaliella multiplies by 
lengthwise division, but sexual reproduction does occur rarely by isogametes with a 
conjugation process. It proliferates in extremely varied salinities from 0.5 to 5.0 M NaCl. The 
alga cells do not contain a rigid cell wall; instead a thin elastic membrane surrounds them. It 
is known to accumulate carotenoids under various stress conditions. It possesses a 
remarkable degree of environmental adaptation by producing an excess of ǃ-carotene and 
glycerol to maintain its osmotic balance. ǃ-carotene occurs naturally as its isomers, namely, 
all-trans, 9-cis, 13-cis, and 15-cis forms and functions as an accessory light harvesting 
pigment, thereby protecting the photosynthetic apparatus against photo damage in all green 
plants including algae. ǃ-carotene, a component of the photosynthetic reaction center is 
accumulated as lipid globules in the interthylakoid spaces of the chloroplasts of Dunaliella. 
They protect the algae from damage obtained during excessive irradiance by preventing the 
formation of reactive oxygen species, by quenching the triplet-state chlorophyll, or by 
reacting with singlet oxygen (1O2) and also act as a light filter (Ben-Amotz, 2004). Dunaliella 
nutraceutical properties are shown in table 
 
Study Conclusion 
In vivo antioxidant activity of carotenoids 
from Dunaliella salina a green microalga     
(Chidambara-Murthy et al., 2005) 
Carotenoids provide protection against 
CCl4-caused hepatic damage by restoring 
the activity of hepatic enzymes like 
peroxidase, super oxide dismutase, and 
catalase, which reduce ROS and lipid 
peroxidation. 
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Study Conclusion 
9-cis ǃ-carotene-rich powder of the alga 
Dunaliella bardawil increases plasma HDL-
cholesterol in fibrate-treated patients 
(Shaish et al., 2006) 
Dunaliella treatment increases plasma 
HDL-cholesterol and lower plasma 
triglyceride levels 
Ethanol extract of Dunaliella salina induces 
cell cycle arrest and apoptosis in A545 
human non-small cell lung cancer cells  
(Sheu et al., 2008) 
Ethanol extract of Dunaliella salina inhibits 
cell proliferation and causes apoptosis 
possibly via p53 and p21 promoting the 
protein expression of Fas and FasL 
Protective effects of Dunaliella salina against 
experimental induced fibrosarcoma on 
Wistar rats (Raja et al., 2007). 
The chlorophyta has a protective effect 
against experimentally caused 
fibrosarcoma 
Bioavailability of the isomer mixture of 
phytoene and phytofluene-rich alga 
Dunaliella bardawil in rat plasma and tissues  
(Werman et al., 2002). 
9-cis phytoene has a stronger antioxidative 
effect than the all trans isomer 
Hypercholesterolemia induced oxidative 
stress is reduced in rats with diets enriched 
with supplement from Dunaliella salina 
algae  (Bansal & Sapna, 2011). 
Dunaliella salina components inhibit lipid 
peroxidation and also  increases Type1 5´-
iodothyronine deiodinase (5´-DI) 
expression, which leads to a T3 level 
increase    
Evaluation of carotenoid extract from 
Dunaliella salina against cadmium-induced 
cytotoxicity and transforming growth 
factor 1 induced expression of smooth 
muscle -actin with rat liver cell lines (Jau-
Tien et al., 2011). 
Carotenoid extract of Dunaliella salina 
contains abundant cis and trans -
carotenes. These antioxidants decrease the 
lipid peroxidation and also inhibit 
activation of hepatic stellate cells (HSCs). 
Protective effects of Dunaliella salina- a 
carotenoids-rich alga, against carbon 
tetrachloride-induced hepatotoxicity in 
mice (Hsu et al., 2008). 
Carotenoids of D. salina inhibit the lipid 
peroxidation and increases the antioxidant 
enzyme activity 
 
Table 5. Nutraceutical evidences of Dunaliella. 
10. Final remarks 
The functional food and nutraceutical market is growing. However, to promote health the 
active compounds must be ingested in high concentration. This is a great problem because 
sometimes the components such as carotenoids, polyphenols, and chlorophylls are extracted 
from vegetables or plants. In their production, we are modifying the environment, thus the 
use of biotechnology of microalgae or other microorganisms like bacteria or fungus could be 
an alternative because they may be environmentally friendly. The sun can be used as energy 
source and the medium could be fresh or sea water, with the carbon source as CO2 and other 
inorganic or organic sources. In this chapter we show the evidence of some genera, 
particularly of Chlorophyceae class as Chlorella, Chlamydomonas, Haematococcus, and 
Dunaliella. It is evident that their components modulate intracellular communication and 
they act as antioxidants.  
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There are many microalgae never used as nutraceuticals that could be used for human or 
animal health, such as the microalgae used in aquaculture to fed shrimp and fish. Examples 
of those kinds of microalgi are Pavlova and Tetraselmis that produce high concentration of 
PUFAs.  
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